“…It also signifi cantly reduces morbidity and mortality in stable chronic heart failure patients (Ishiguro et al, 2008;De Groote et al, 2007;Metra et al, 2007). Several previous reports have described the determination of bisoprolol in plasma using analytical methods including HPLC-FL (Taguchi et al, 2005;Braza et al, 2002;Eastwood et al, 1990;Horikiri et al, 1998), HPLC-DAD (Caudron et al, 2004), GC-MS (Shangguan et al, 2008) and LC-MS/MS Ding et al, 2007;Jovanovic et al, 2006;Bhatt et al, 2007;Kristoff ersen et al, 2007;Maurer et al, 2004). These HPLC methods have usually adopted a liquid-liquid extraction procedure which involves tedious drying and reconstitution processes and which requires a large sample volume.…”